The reduction is small and typical for a passive manager; no signal of negative conviction. Monitor future 13G filings for further trimming, but this filing alone does not warrant action.
ELAN drugs
ELAN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $26.78entry
- T+1 · 21h ago −1.38%α +0.53% · $26.41
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dodge & Cox filed an amended Schedule 13G disclosing a 12.3% passive stake in Elanco Animal Health as of September 30, 2026, down from 13.3% in the prior filing. The reduction is modest and consistent with routine portfolio rebalancing by a passive investment manager.
Key Financial Metrics
Key Facts
- Dodge & Cox reported beneficial ownership of 61,430,997 shares of Elanco Animal Health common stock as of September 30, 2026
- The stake represents 12.3% of shares outstanding, down from 13.3% in the prior filing (May 2026)
- Dodge & Cox Stock Fund holds 38,409,300 shares or 7.7% of the class
- The filing is a passive Schedule 13G/A under Rule 13d-1(b)
Financial Impact
Stake decreased by approximately 1.0 percentage point (from 13.3% to 12.3%)
Risk Factors
- Continued gradual selling by Dodge & Cox could pressure the stock over time
- No indication of activist intent; passive filing status confirmed
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001193125-26-458582 |
| Document: 0001193125-26-458582-index.html | 0001193125-26-458582 |
| Document: 0001193125-26-458582.txt | 0001193125-26-458582 |
Track record
19 reports on ELAN
5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +15.03% at T+5 after the May 19, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $26.68 Now $26.41 −1.01% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Viewing Entry $26.78 Now $26.41 −1.38% settles Feb 11
- Nov 6, 202610d ago 8-K Bullish 6/10 Entry $25.74 Now $26.41 +2.60% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $23.68 Now $26.41 +11.53% settles Feb 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $25.31 Now $26.41 +4.35% settles Feb 2
- Oct 14, 20264w ago Institutional Cluster Bullish 4/10 Entry $23.54 Now $26.41 +12.19% settles Jan 12
- Sep 11, 20269w ago Press Release Neutral 1/10 Entry $23.17 Now $26.41 +13.98% settles Dec 7
- Aug 21, 202612w ago Insider Cluster Bullish 6/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 21, 202612w ago Insider Cluster Bullish 4/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 18, 202612w ago Insider Cluster Bullish 4/10 Entry $24.50 to $26.50 Now $26.41 +7.80% ▲ +8.16% +9.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers